FeesSafety
Pluang+

Laureate Education reports 21% revenue growth in Q3 2026 and boosts share buyback by $150M

Company Fundamentals
29 Oct 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Laureate Education reports 21% revenue growth in Q3 2026 and boosts share buyback by $150M

Laureate Education, operating universities in Mexico and Peru, reported a 21% revenue increase to $485.1 million in Q3 2026, driven by higher enrollments and academic calendar timing. Net income rose to $101.2 million, supported by a $25.4 million tax benefit. For the first nine months, revenue grew 18% to $1.37 billion with a 9% rise in new enrollments. The company also increased its share repurchase authorization by $150 million, reflecting strong financial performance and confidence in future growth.

Laureate Education's financial results provide context for readers. For those tracking Consumer Cyclical stocks, 84 of 134 US stocks rose while 40 fell on Pluang. Notable prices as of Oct 29, 2026 17:42 WIB include Alibaba Group at USD 98.91 with a 2.03% decrease, Booking Holdings Inc at USD 150.84 with a 1.96% increase, and Starbucks Corp at USD 105.20 with a 1.94% increase.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App